482311-23-9

Basic information

• Product Name: Methyl 3-Methyl-5-nitrobenzoate
• Synonyms: Methyl 3-Methyl-5-nitrobenzoate
• CAS NO: 482311-23-9
• Molecular Formula: C9H9NO4
• Molecular Weight: 195.17206
• Mol File: 482311-23-9.mol

Chemical Properties

• Melting Point: 84-85 °C
• Boiling Point: 315.0±22.0 °C(Predicted)
• Appearance: /
• Density: 1 +-.0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl 3-Methyl-5-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-Methyl-5-nitrobenzoate(482311-23-9)
• EPA Substance Registry System: Methyl 3-Methyl-5-nitrobenzoate(482311-23-9)

Safety Data

• Hazardous Substances Data: 482311-23-9(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 113882-33-0 5-Methyl-3-nitrobenzoic acid 
• 117342-20-8 (3-(methoxycarbonyl)-5-nitrophenyl)boronic acid 
• 74-88-4 methyl iodide 
• 99-12-7 5-nitro-m-xylene 

Relevant articles and documents

BCL-2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS

The disclosure is directed to, in part, to BCL-2 inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

FUSED BICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE

Fused bicyclic compounds and uses thereof in medicine. In particular, provided are fused bicyclic compounds used as ASK1 active regulator and and use of the compounds in the manufacture of a drug for treating a disease regulated by ASK1. Further provided are a pharmaceutical composition and a method of treating a disease regulated by ASK1 comprising administering the compounds or pharmaceutical composition thereof.

PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH

The invention relates to MKK4 (mitogen-activated protein kinase 4) and their use in promoting liver regeneration or reducing or preventing hepatocyte death. The MKK4 inhibitors selectively inhibit protein kinase MKK4 over protein kinases JNK and MKK7.

BENZAMIDE FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

The present invention provides novel benzamide derivatives of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, W, Y, Z, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.